C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/64 (2006.01) A61K 38/08 (2006.01) C07K 14/46 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2295219
Cyclic peptides comprising three colinear amino acids, arginine-lysine-lysine (RKK) are provided that bind to the integrin .alpha.21 domain and are potent inhibitors of its interaction with collagens I and IV and laminin-1. Methods of using such peptides to block integrin function and to inhibit cell migration are also provided.
Peptides cycliques comprenant trois acides aminés colinéaires, arginine-lysine-lysine (RKK), présentant une liaison avec le domaine alpha 2I d'intégrine et constituant des inhibiteurs puissants de son interaction avec des collagènes I et IV et laminine-1. Procédés servant à utiliser ces peptides afin de bloquer la fonction d'intégrine et d'inhiber la migration cellulaire.
Heino Jyrki
Ivaska Johanna
Kapyla Jarmo
Biotie Therapies Corp.
Oy Biotie Therapies Ltd.
Robic
LandOfFree
Integrin binding peptide and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Integrin binding peptide and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin binding peptide and use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1514674